Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aequus Pharmaceuticals Inc (AQS.VN)

Aequus Pharmaceuticals Inc (AQS.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 15,916
  • Shares Outstanding, K 132,634
  • Annual Sales, $ 2,593 K
  • Annual Income, $ -1,045 K
  • 60-Month Beta 0.56
  • Price/Sales 5.21
  • Price/Cash Flow N/A
  • Price/Book 6.56
Trade AQS.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings 0.00 on 06/30/21
  • Next Earnings Date 08/26/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.110 +9.09%
on 09/17/21
0.160 -25.00%
on 08/23/21
-0.005 (-4.00%)
since 08/17/21
3-Month
0.100 +20.00%
on 06/18/21
0.160 -25.00%
on 08/23/21
-0.005 (-4.00%)
since 06/17/21
52-Week
0.090 +33.33%
on 12/29/20
0.290 -58.62%
on 03/01/21
unch (unch)
since 09/17/20

Most Recent Stories

More News
Aequus Reports Second Quarter 2021 Financial Highlights

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertise

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus") a speciality pharmaceutical company, is pleased to announce that Dr. Robert K. Koenekoop MD, MSc, PhD, FRCS(C), FARVO has joined as a medical...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus and reVision to Collaborate on Stargardt Disease Program

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus") and reVision Therapeutics, Inc. ("reVision") announce a collaboration on the development of a therapy for Stargardt disease. Aequus is...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides Commercial Update

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides General Update and First Quarter 2021 Financial Highlights

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides General Update and Reports Record 2020 Financial Results

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference

Aequus Pharmaceuticals Inc. (TSX: AQS, OTCQB: AQSZF), a Canadian based specialty pharmaceutical company, will be presenting at the 2021 Bloom Burton & Co. Healthcare Investor Conference. Chairman and CEO,...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Provides update on Warrant Acceleration

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Announces Notice of Warrant Acceleration

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)
Aequus Launches Evolve Eyedrops to Eye Care Professionals in Canada

Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a Canadian specialty pharmaceutical company announces the commercial availability of Evolve preservative free lubricating...

AQS.VN : 0.120 (+4.35%)
AQSZF : 0.0942 (-11.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.142
2nd Resistance Point 0.133
1st Resistance Point 0.127
Last Price 0.120
1st Support Level 0.112
2nd Support Level 0.103
3rd Support Level 0.097

See More

52-Week High 0.290
Fibonacci 61.8% 0.214
Fibonacci 50% 0.190
Fibonacci 38.2% 0.166
Last Price 0.120
52-Week Low 0.090

See More

Business Summary

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar